Endeavor BioMedicines Welcomes ILD Expert Dr. Lisa Lancaster as Chief Medical Officer Endeavor BioMedicines, a clinical-stage biotechnology company dedicated to developing groundbreaking treatments for life-threatening diseases, has announced the appointment of Lisa Lancaster, M.D., as its new Chief Medical Officer.…
Thermo Fisher Unveils Krios 5 Cryo-TEM for Enhanced Automation & Performance Thermo Fisher Scientific, a global leader in scientific innovation, has introduced the Thermo Scientific™ Krios™ 5 Cryo-TEM, a cutting-edge, atomic-resolution platform designed to revolutionize molecular imaging. By integrating enhanced…
Personalized Cancer Vaccine Market & Clinical Trials Outlook 2025 – 18+ Vaccines in Development The “Personalized Cancer Vaccine Market Opportunity & Clinical Trials Outlook 2025″ report, now available from ResearchAndMarkets.com, highlights the growing significance of personalized cancer vaccines in the…
AGC Biologics Launches New Cell & Gene Technology Division AGC Biologics, a leading Contract Development and Manufacturing Organization (CDMO), has announced the launch of its new Cell and Gene Technology division, an initiative designed to further strengthen the company’s technical…
Parse Biosciences Announces Partnership with Japanese Distributor SCRUM Inc. Parse Biosciences, a leading provider of scalable and accessible single-cell sequencing solutions, has announced a strategic partnership with Tokyo-based SCRUM Inc. to expand its footprint in Japan’s research community. This collaboration…
AustinPx Introduces KinetiSol™ Equipment Leasing Program AustinPx, a leading contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement for orally administered small molecule drugs, has announced the launch of its groundbreaking KinetiLease™ program. This initiative allows pharmaceutical companies to…
Unlearn and Trace Neuroscience Collaborate to Enhance ALS Clinical Trials Unlearn®, a leader in AI-powered solutions for clinical trials, has announced a strategic collaboration with Trace Neuroscience, a biotechnology company specializing in genomic therapies for neurodegenerative diseases. This partnership is…
Align Technology Launches Invisalign® With Mandibular Advancement for Class II Correction Align Technology, Inc. (Nasdaq: ALGN), a globally recognized medical device company specializing in digital orthodontics and restorative dentistry, has announced the commercial availability of its latest innovation: the Invisalign…
MANSCAPED Unveils TCS Ball Hero Bundle for Testicular Cancer Awareness MANSCAPED, the global leader in men’s grooming, has built a reputation not only for its innovative grooming products and clever marketing but also for its commitment to a cause that…
Devonian Announces Delay in Financial Results Release Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical-stage biopharmaceutical company specializing in the development of innovative therapies for inflammatory diseases, has announced a delay in filing its…
LucyRx Unveils Bold Brand Identity, Celebrates Key Milestones to Simplify PBM and Enhance Patient Care LucyRx, a next-generation pharmacy benefit manager (PBM), is shaking up the landscape of prescription care with its innovative approach, compassionate values, and impressive growth. With…
Omeros Corporation Announces Fourth Quarter and Full-Year 2024 Financial Results Omeros Corporation has announced its recent developments, clinical updates, and financial results for the fourth quarter and full year ended December 31, 2024. Financial Highlights: Clinical Developments: Other Developments: CEO’s…